pillbase.ru

Trelegy Ellipta

Active substance: FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

POWDER · FLUTICASONE FUROATE 100 ug/1, UMECLIDINIUM BROMIDE 62.5 ug/1, VILANTEROL TRIFENATATE 25 ug/1

United StatesActive

Marketing holder: GlaxoSmithKline LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing fluticasone furoate in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
EU 7
  • Alisade
    fluticasone furoate
    EMEA/H/C/001019
    Glaxo Group Ltd.
  • Avamys
    fluticasone furoate
    EMEA/H/C/000770
    GlaxoSmithKline Trading Services Limited
  • Elebrato Ellipta
    fluticasone furoate, umeclidinium bromide, vilanterol trifenatate
    EMEA/H/C/004781
    GlaxoSmithKline Trading Services Limited
  • Relvar Ellipta
    fluticasone furoate, vilanterol
    EMEA/H/C/002673
    GlaxoSmithKline Trading Services Limited
  • Revinty Ellipta
    fluticasone furoate, vilanterol trifenatate
    EMEA/H/C/002745
    GlaxoSmithKline Trading Services Limited
All products in this country (7)
Registration
Registration number
0173-0887
Registration status
Active
Dispensing
Prescription only
Route
RESPIRATORY (INHALATION)
Sources
  • product · openFDA NDC · 0173-0887 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0173-0887 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0173-0887 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 0173-0887 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 0173-0887 · Verified 2026-10-09 · open in source